Vanguard Group
KALV icon

Vanguard Group’s KalVista Pharmaceuticals KALV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$27.3M Buy
2,412,399
+113,801
+5% +$1.29M ﹤0.01% 2408
2025
Q1
$26.5M Buy
2,298,598
+43,355
+2% +$500K ﹤0.01% 2376
2024
Q4
$19.1M Buy
2,255,243
+104,716
+5% +$887K ﹤0.01% 2610
2024
Q3
$24.9M Buy
2,150,527
+159,939
+8% +$1.85M ﹤0.01% 2482
2024
Q2
$23.4M Buy
1,990,588
+305,475
+18% +$3.6M ﹤0.01% 2490
2024
Q1
$20M Sell
1,685,113
-96,306
-5% -$1.14M ﹤0.01% 2596
2023
Q4
$21.8M Buy
1,781,419
+48,930
+3% +$599K ﹤0.01% 2555
2023
Q3
$16.7M Buy
1,732,489
+151,808
+10% +$1.46M ﹤0.01% 2617
2023
Q2
$14.2M Sell
1,580,681
-1,845
-0.1% -$16.6K ﹤0.01% 2750
2023
Q1
$12.4M Buy
1,582,526
+429,853
+37% +$3.38M ﹤0.01% 2822
2022
Q4
$7.79M Buy
1,152,673
+2,812
+0.2% +$19K ﹤0.01% 3067
2022
Q3
$16.7M Sell
1,149,861
-7,297
-0.6% -$106K ﹤0.01% 2709
2022
Q2
$11.4M Sell
1,157,158
-9,494
-0.8% -$93.4K ﹤0.01% 2921
2022
Q1
$17.2M Buy
1,166,652
+28,168
+2% +$415K ﹤0.01% 2854
2021
Q4
$15.1M Sell
1,138,484
-48,263
-4% -$639K ﹤0.01% 2988
2021
Q3
$20.7M Buy
1,186,747
+222,328
+23% +$3.88M ﹤0.01% 2846
2021
Q2
$23.1M Buy
964,419
+34,938
+4% +$837K ﹤0.01% 2765
2021
Q1
$23.9M Buy
929,481
+361,933
+64% +$9.3M ﹤0.01% 2693
2020
Q4
$10.8M Buy
567,548
+8,695
+2% +$165K ﹤0.01% 2957
2020
Q3
$7.04M Sell
558,853
-479
-0.1% -$6.03K ﹤0.01% 2974
2020
Q2
$6.77M Sell
559,332
-861
-0.2% -$10.4K ﹤0.01% 2948
2020
Q1
$4.29M Buy
560,193
+10,174
+2% +$77.8K ﹤0.01% 3035
2019
Q4
$9.8M Buy
550,019
+5,971
+1% +$106K ﹤0.01% 2868
2019
Q3
$6.31M Buy
544,048
+16,219
+3% +$188K ﹤0.01% 3047
2019
Q2
$11.7M Buy
527,829
+170,439
+48% +$3.78M ﹤0.01% 2773
2019
Q1
$10.2M Buy
357,390
+16,547
+5% +$474K ﹤0.01% 2810
2018
Q4
$6.73M Buy
340,843
+44,262
+15% +$874K ﹤0.01% 2950
2018
Q3
$6.56M Buy
296,581
+179,092
+152% +$3.96M ﹤0.01% 3135
2018
Q2
$954K Buy
117,489
+394
+0.3% +$3.2K ﹤0.01% 3702
2018
Q1
$1.11M Sell
117,095
-1,243
-1% -$11.8K ﹤0.01% 3627
2017
Q4
$1.15M Sell
118,338
-81,280
-41% -$793K ﹤0.01% 3577
2017
Q3
$1.33M Buy
199,618
+18,746
+10% +$125K ﹤0.01% 3516
2017
Q2
$1.3M Buy
180,872
+100
+0.1% +$720 ﹤0.01% 3510
2017
Q1
$1.41M Buy
180,772
+141,476
+360% +$1.11M ﹤0.01% 3487
2016
Q4
$278K Sell
39,296
-387,372
-91% -$2.74M ﹤0.01% 3836
2016
Q3
$196K Sell
426,668
-118,071
-22% -$54.2K ﹤0.01% 3906
2016
Q2
$361K Sell
544,739
-12,819
-2% -$8.5K ﹤0.01% 3847
2016
Q1
$358K Buy
557,558
+144,031
+35% +$92.5K ﹤0.01% 3854
2015
Q4
$1.5M Buy
413,527
+125,242
+43% +$453K ﹤0.01% 3502
2015
Q3
$1.03M Buy
288,285
+63,173
+28% +$225K ﹤0.01% 3620
2015
Q2
$1.61M Buy
+225,112
New +$1.61M ﹤0.01% 3506